The HNRNP2AB1 promoter is fused to ETS factors in some prostate cancer patients and this promoter results in lower, more physiological ERG expression than CMV promoter constructs, but can still drive cell migration and tumor growth (23,36). The gene discussed is ERG; the disease is neoplasm.